Bazel International Gains BSE Listing Approval
Bazel International Ltd. announced it has received approval from BSE Limited to list 21,04,802 equity shares. These shares were issued on a preferential basis after warrants were converted. The price for these shares was set at ₹42.12 each, which included a ₹32.12 premium over the ₹10 face value.
Increased Liquidity and Share Capital
This BSE approval means the newly issued shares will soon be available for trading. The development is expected to raise Bazel International's paid-up share capital and enhance the liquidity and public float of its stock, potentially making it more appealing to investors.
Warrant Conversion Underpins Approval
The listing approval stems from Bazel International's prior issuance of warrants, which have now been converted into equity shares. This preferential issue method allows companies to raise funds from select investors at a pre-set price.
Trading Readiness on the Horizon
Following the BSE's green light, Bazel International's total paid-up share capital will grow. Shareholders can anticipate these shares becoming tradable, pending the company's completion of necessary steps for trading authorization.
Compliance Deadline Key Risk
A significant risk is the potential penalty if Bazel International does not apply for trading approval within seven working days of receiving the listing approval, as required by SEBI regulations.
Monitoring Future Steps
Investors should track Bazel International's adherence to the seven-day deadline for the trading approval application. Any updates on listing approval from the National Stock Exchange (NSE), if sought, and confirmation of share credit and lock-in status from depositories like NSDL and CDSL will also be noteworthy.
